anamiR: integrated analysis of MicroRNA and gene expression profiling
暂无分享,去创建一个
Tzu-Pin Lu | Eric Y. Chuang | Liang-Chuan Lai | Mong-Hsun Tsai | Ti-Tai Wang | Chien-Yueh Lee | E. Chuang | M. Tsai | L. Lai | Chien-Yueh Lee | T. Lu | Ti-Tai Wang
[1] Y. Kondo,et al. Histone Deacetylase Inhibition in Prostate Cancer Triggers miR-320-Mediated Suppression of the Androgen Receptor. , 2016, Cancer research.
[2] Hong‐Tai Chang,et al. Comprehensive microRNA profiling of prostate cancer cells after ionizing radiation treatment , 2014, Oncology reports.
[3] C. K. Hsiao,et al. miRSystem: An Integrated System for Characterizing Enriched Functions and Pathways of MicroRNA Targets , 2012, PloS one.
[4] Mihaela Zavolan,et al. Inference of miRNA targets using evolutionary conservation and pathway analysis , 2007, BMC Bioinformatics.
[5] T. Hong,et al. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. , 2013, Carcinogenesis.
[6] Martin Reczko,et al. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows , 2013, Nucleic Acids Res..
[7] Maria Vila-Casadesús,et al. MiRComb: An R Package to Analyse miRNA-mRNA Interactions. Examples across Five Digestive Cancers , 2016, PloS one.
[8] Xiong Guo,et al. Let-7b-5p regulates proliferation and apoptosis in multiple myeloma by targeting IGF1R. , 2014, Acta biochimica et biophysica Sinica.
[9] Fei Guo,et al. MDA-SKF: Similarity Kernel Fusion for Accurately Discovering miRNA-Disease Association , 2018, Front. Genet..
[10] B. Berger,et al. Unusually effective microRNA targeting within repeat-rich coding regions of mammalian mRNAs. , 2011, Genome research.
[11] Qianben Wang,et al. Phospho‐MED1‐enhanced UBE2C locus looping drives castration‐resistant prostate cancer growth , 2011, The EMBO journal.
[12] S. Rossi,et al. MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression. , 2016, The Journal of clinical investigation.
[13] Sam Griffiths-Jones,et al. Bias in microRNA functional enrichment analysis , 2015, Bioinform..
[14] P. Tassone,et al. MicroRNAs in multiple myeloma and related bone disease. , 2015, Annals of translational medicine.
[15] N. Gao,et al. miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1. , 2016, Biochemical and biophysical research communications.
[16] Shuliang Song,et al. Involvement of ubiquitin-conjugating enzyme E2C in proliferation and invasion of prostate carcinoma cells. , 2014, Oncology research.
[17] Michael Kertesz,et al. The role of site accessibility in microRNA target recognition , 2007, Nature Genetics.
[18] Isidore Rigoutsos,et al. Interactive exploration of RNA22 microRNA target predictions , 2012, Bioinform..
[19] P. Tassone,et al. MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment , 2016, BioMed research international.
[20] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..
[21] Ivo Grosse,et al. Functional microRNA targets in protein coding sequences , 2012, Bioinform..
[22] D. Lancet,et al. GeneCards: integrating information about genes, proteins and diseases. , 1997, Trends in genetics : TIG.
[23] Jijun Tang,et al. FKL-Spa-LapRLS: an accurate method for identifying human microRNA-disease association , 2018, BMC Genomics.
[24] G. Nuovo,et al. Experimental validation of miRNA targets. , 2008, Methods.
[25] Rongguo Fu,et al. Advances in the Techniques for the Prediction of microRNA Targets , 2013, International journal of molecular sciences.
[26] Xiaowei Wang. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. , 2008, RNA.
[27] Carol J Bult,et al. MouseCyc: a curated biochemical pathways database for the laboratory mouse , 2009, Genome Biology.
[28] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[29] Lincoln Stein,et al. Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..
[30] Gordon K. Smyth,et al. limma: Linear Models for Microarray Data , 2005 .
[31] Peter J. Woolf,et al. GAGE: generally applicable gene set enrichment for pathway analysis , 2009, BMC Bioinformatics.
[32] M. Schmidt‐Hieber,et al. Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region , 2015, BMC Cancer.
[33] Hsien-Da Huang,et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database , 2015, Nucleic Acids Res..
[34] I. Riquelme,et al. Tools for Sequence-Based miRNA Target Prediction: What to Choose? , 2016, International journal of molecular sciences.
[35] Tongbin Li,et al. miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..
[36] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[37] Yoshihiro Yamanishi,et al. KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..
[38] H. Klocker,et al. Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway. , 2012, Carcinogenesis.
[39] Jeffrey A. Thompson,et al. Common features of microRNA target prediction tools , 2014, Front. Genet..
[40] J. Rivas,et al. Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling , 2010, Leukemia.
[41] J. Davis. Bioinformatics and Computational Biology Solutions Using R and Bioconductor , 2007 .
[42] Doron Betel,et al. The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..
[43] N. Munshi,et al. Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance. , 2009, Blood.